• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含亮氨酸重复序列激酶2(LRRK2)GTP酶和激酶结构域的结构生物学:对调节的启示

Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation.

作者信息

Gilsbach Bernd K, Kortholt Arjan

机构信息

Department of Cell Biochemistry, University of Groningen Groningen, Netherlands.

出版信息

Front Mol Neurosci. 2014 May 5;7:32. doi: 10.3389/fnmol.2014.00032. eCollection 2014.

DOI:10.3389/fnmol.2014.00032
PMID:24847205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4017136/
Abstract

Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain. Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD). Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function. Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms. Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of molecular switches (G proteins activated by nucleotide dependent dimerization). As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction. Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity. Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors. In this review we highlight the recent progress in structural and biochemical characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.

摘要

人类富含亮氨酸重复激酶2(LRRK2)属于Roco蛋白家族,其特征是存在一个类Ras G结构域(Roc)、一个Roc结构域的C末端(COR)和一个激酶结构域。迄今为止,已发现LRRK2突变是迟发性帕金森病(PD)最常见的病因。LRRK2中的几种致病突变导致GTPase活性降低和激酶活性增强,提示可能存在与PD相关的异常功能获得。我们对低等生物中相关Roco蛋白的研究在LRRK2结构理解方面取得了重要进展。原核生物Roco蛋白的原子结构表明,Roco蛋白属于分子开关的GAD类(由核苷酸依赖性二聚化激活的G蛋白)。与LRRK2一样,细菌中Roco蛋白的PD类似突变会降低GTPase反应。对模式生物盘基网柄菌中Roco蛋白的研究表明,PD突变体有不同的作用,最重要的是它们解释了与G2019S相关的LRRK2激酶活性增加。此外,盘基网柄菌Roco4激酶与LRRK2抑制剂H1152复合物的结构表明,Roco4和其他Roco家族蛋白对于优化当前的LRRK2激酶抑制剂以及鉴定新的抑制剂可能很重要。在这篇综述中,我们重点介绍了Roco蛋白在结构和生化特性方面的最新进展,并讨论了其对理解LRRK2复杂调控机制的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/defe978e3659/fnmol-07-00032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/185a2f5c68e1/fnmol-07-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/fbfc7633dccf/fnmol-07-00032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/b363caff834e/fnmol-07-00032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/defe978e3659/fnmol-07-00032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/185a2f5c68e1/fnmol-07-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/fbfc7633dccf/fnmol-07-00032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/b363caff834e/fnmol-07-00032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5f4/4017136/defe978e3659/fnmol-07-00032-g004.jpg

相似文献

1
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation.富含亮氨酸重复序列激酶2(LRRK2)GTP酶和激酶结构域的结构生物学:对调节的启示
Front Mol Neurosci. 2014 May 5;7:32. doi: 10.3389/fnmol.2014.00032. eCollection 2014.
2
Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.嗜热栖热菌Roc-COR中Roc结构域的构象异质性及其对人类LRRK2帕金森突变的影响。
Biosci Rep. 2015 Aug 26;35(5):e00254. doi: 10.1042/BSR20150128.
3
The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties.富含亮氨酸重复激酶 2 的 Roc-COR 串联结构域形成二聚体,并表现出常规 Ras 样 GTP 酶特性。
J Neurochem. 2018 Nov;147(3):409-428. doi: 10.1111/jnc.14566.
4
Revisiting the Roco G-protein cycle.重新审视Roco G蛋白循环。
Biochem J. 2015 Jan 1;465(1):139-47. doi: 10.1042/BJ20141095.
5
The unconventional G-protein cycle of LRRK2 and Roco proteins.LRRK2和Roco蛋白的非常规G蛋白循环
Biochem Soc Trans. 2016 Dec 15;44(6):1611-1616. doi: 10.1042/BST20160224.
6
Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.了解富含亮氨酸重复激酶2(LRRK2)的GTP酶活性:调控、功能及神经毒性
Adv Neurobiol. 2017;14:71-88. doi: 10.1007/978-3-319-49969-7_4.
7
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment.ROCO激酶的同源和异源二聚化:LRRK2的ROCO片段对LRRK2激酶的抑制作用
J Neurochem. 2009 Nov;111(3):703-15. doi: 10.1111/j.1471-4159.2009.06358.x. Epub 2009 Aug 27.
8
The Parkinson disease gene LRRK2: evolutionary and structural insights.帕金森病基因LRRK2:进化与结构洞察
Mol Biol Evol. 2006 Dec;23(12):2423-33. doi: 10.1093/molbev/msl114. Epub 2006 Sep 11.
9
Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations.Roco 激酶结构为帕金森病相关富亮氨酸重复激酶 2 突变的机制提供了见解。
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10322-7. doi: 10.1073/pnas.1203223109. Epub 2012 Jun 11.
10
Roco Proteins: GTPases with a Baroque Structure and Mechanism.Roco 蛋白:具有巴洛克结构和机制的 GTPases。
Int J Mol Sci. 2019 Jan 3;20(1):147. doi: 10.3390/ijms20010147.

引用本文的文献

1
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state.14-3-3蛋白结合可使帕金森相关激酶LRRK2维持在非活性状态。
Nat Commun. 2025 Aug 5;16(1):7226. doi: 10.1038/s41467-025-62337-1.
2
Parkinson's disease: genetics and neuroinflammatory insights.帕金森病:遗传学与神经炎症见解
Inflammopharmacology. 2025 Jul 3. doi: 10.1007/s10787-025-01832-9.
3
Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component.进行性核上性麻痹(PSP)的多因素病因:遗传因素

本文引用的文献

1
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.LRRK2 中的帕金森病相关突变 R1441H 延长了其 GTPase 结构域的“活性状态”。
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4055-60. doi: 10.1073/pnas.1323285111. Epub 2014 Mar 3.
2
Structural and functional in silico analysis of LRRK2 missense substitutions.富含亮氨酸重复激酶2错义替换的结构与功能计算机模拟分析
Mol Biol Rep. 2014;41(4):2529-42. doi: 10.1007/s11033-014-3111-z. Epub 2014 Feb 2.
3
Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2).
Acta Neuropathol. 2025 Jun 4;149(1):58. doi: 10.1007/s00401-025-02898-z.
4
LRRK2 interactions with microtubules are independent of LRRK2-mediated Rab phosphorylation.LRRK2与微管的相互作用独立于LRRK2介导的Rab磷酸化。
EMBO Rep. 2025 May 27. doi: 10.1038/s44319-025-00486-6.
5
The Leucine-Rich Repeat Kinase 2 Variant LRRK2 Up-Regulates L-Type (CaV1.3) Calcium Channel via the Caβ Subunit: Possible Role in the Pathogenesis of Parkinson's Disease.富含亮氨酸重复激酶2变体LRRK2通过Caβ亚基上调L型(CaV1.3)钙通道:在帕金森病发病机制中的可能作用。
Int J Mol Sci. 2025 Mar 31;26(7):3229. doi: 10.3390/ijms26073229.
6
Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S.用于表征LRRK2 G2019S效应的轴突溶酶体测定法。
Biology (Basel). 2024 Jan 20;13(1):58. doi: 10.3390/biology13010058.
7
LRRK2 Structure-Based Activation Mechanism and Pathogenesis.LRRK2 结构基础激活机制与发病机制。
Biomolecules. 2023 Mar 28;13(4):612. doi: 10.3390/biom13040612.
8
LRRK2 and Parkinson's disease: from genetics to targeted therapy.LRRK2 与帕金森病:从遗传学研究到靶向治疗。
Ann Clin Transl Neurol. 2023 Jun;10(6):850-864. doi: 10.1002/acn3.51776. Epub 2023 Apr 6.
9
Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.过去十年中用于帕金森病的 LRRK2 抑制剂的结构见解和研发进展。
Genes (Basel). 2022 Aug 11;13(8):1426. doi: 10.3390/genes13081426.
10
High-Throughput Sequencing Haplotype Analysis Indicates in Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic.高通量测序单倍型分析表明,在捷克共和国摩拉维亚东南部,基因是地方性帕金森病的一个潜在风险因素。
Life (Basel). 2022 Jan 14;12(1):121. doi: 10.3390/life12010121.
富含亮氨酸重复激酶2(LRRK2)重复结构域结构的预测以及帕金森症相关变异对其所有功能域结构和功能的影响。
Hum Mutat. 2014 Apr;35(4):395-412. doi: 10.1002/humu.22515. Epub 2014 Feb 24.
4
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.LRRK2与ARHGEF7和原肌球蛋白4一起在生长锥处引导肌动蛋白细胞骨架。
Biochim Biophys Acta. 2013 Dec;1832(12):2352-67. doi: 10.1016/j.bbadis.2013.09.009. Epub 2013 Sep 24.
5
Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.在特发性帕金森病患者的外周血单核细胞中测量 LRRK2 和 Ser910/935 磷酸化 LRRK2。
J Parkinsons Dis. 2013;3(2):145-52. doi: 10.3233/JPD-130174.
6
LRRK2 secretion in exosomes is regulated by 14-3-3.LRRK2 在 exosomes 中的分泌受 14-3-3 的调节。
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.
7
Leucine-rich repeat kinase 2 (LRRK2)-deficient rats exhibit renal tubule injury and perturbations in metabolic and immunological homeostasis.富含亮氨酸重复激酶 2(LRRK2)缺陷大鼠表现出肾小管损伤以及代谢和免疫稳态的紊乱。
PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.
8
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.GTPase 活性调节帕金森病相关 LRRK2 的激酶活性和细胞表型。
Hum Mol Genet. 2013 Mar 15;22(6):1140-56. doi: 10.1093/hmg/dds522. Epub 2012 Dec 13.
9
Brain Penetrant LRRK2 Inhibitor.脑渗透性LRRK2抑制剂。
ACS Med Chem Lett. 2012 Aug 9;3(8):658-662. doi: 10.1021/ml300123a. Epub 2012 Jun 18.
10
Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.激酶抑制剂可阻止 LRRK2 毒性的细胞和秀丽隐杆线虫模型中的神经退行性变。
Hum Mol Genet. 2013 Jan 15;22(2):328-44. doi: 10.1093/hmg/dds431. Epub 2012 Oct 12.